AZILECT (Teva Pharma Australia Pty Ltd)
Product name
AZILECT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
135 working days (255)
Active ingredients
rasagiline
Registration type
EOI
Indication
AZILECT-RASAGILINE is now also indicated as adjunct therapy to dopamine agonist or to levodovap.